Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Vaccine|July 24, 2010
CD4+ T cells reduce the tissue burden of Chlamydia muridarum in male BALB/c miceKelly A Cunningham, Alison J Carey, Peter Timms, et al.
Pediatric Research|March 30, 2017
Characterization of CD31 expression on murine and human neonatal T lymphocytes during development and activationAdam J Fike, Linda T Nguyen, Ogan K Kumova, et al.
Journal of Leukocyte Biology|December 12, 2018
Neonatal influenza-specific effector CTLs retain elevated CD31 levels at the site of infection and have decreased IFN-γ productionAdam J Fike, Ogan K Kumova, Virginie J Tardif, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|July 13, 2010
Chlamydia muridarum major outer membrane protein-specific antibodies inhibit in vitro infection but enhance pathology in vivoKelly A Cunningham, Alison J Carey, Louise Hafner, et al.
Journal of Reproductive Immunology|June 9, 2009
CTA1-DD is an effective adjuvant for targeting anti-chlamydial immunity to the murine genital mucosaKelly A Cunningham, Alison J Carey, Nils Lycke, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 18, 2025
Cathelicidin-related antimicrobial peptide (CRAMP) is toxic during neonatal murine influenza virus infectionAbhishek S Rao, Nneka Ugwu, Abigail P Onufer, et al.
Frontiers in Pediatrics|January 6, 2022
Eliminating Contamination in Umbilical Cord Blood Culture Sampling for Early-Onset Neonatal SepsisVilmaris Quinones Cardona, Vanessa Lowery, David Cooperberg, et al.
Immunology and Cell Biology|February 11, 2009
Effects of inoculating dose on the kinetics of Chlamydia muridarum genital infection in female miceAlison J Carey, Kelly A Cunningham, Louise M Hafner, et al.
Current Molecular Medicine|September 24, 2005
Induction of anti-chlamydial mucosal immunity by transcutaneous immunization is enhanced by topical application of GM-CSFDanica K Hickey, Shisan Bao, Luke T Ikeda, et al.
Pageof 7